AJMC April 22, 2022
Richard S. Isaacson, MD, outlines some of the recent developments in Alzheimer disease diagnoses and treatments.
Precision medicine and genetic testing will reign supreme when it comes to the future of Alzheimer disease care and treatment advancement, according to Richard S. Isaacson, MD, director of the Alzheimer’s Prevention Clinic and associate professor of Neurology at Weill Cornell Medicine and New York-Presbyterian.
Isaacson’s session “Treatment Updates in Alzheimer’s Disease: Tailoring Management and Care Approaches to Improve Outcomes,” was presented at this year’s National Association of Managed Care Physicians Spring Managed Care Forum, held in Orlando, Florida, April 21-22.
Kicking off his presentation, Isaacson remarked on the recent FDA approval and CMS coverage determination of Aduhelm (aducanumab), the first new treatment for...
Today's Sponsors
Today's Sponsor